ADORA2A and Parkinson disease: It was reported that the ADORA2A signaling pathway and the dopamine receptor signaling pathway could competitively regulate microglia-mediated inflammation and improve cognitive dysfunction in patients with Parkinson’s disease by regulating the immune microenvironment (21).